Abstract 7745: Dual versus Single Incretin Receptor Agonism After Atrial Fibrillation Ablation: A Propensity-Matched Cohort Study
Circulation · 02.11.2026 · 154 (Suppl_1)
DOI: 10.1161/circ.154.suppl_1.7745 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Circulation, erschienen am 02.11.2026. Verfasst von Abdul Rasheed Bahar und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Obesity is a major contributor to atrial fibrillation (AF) recurrence following catheter ablation. Tirzepatide has demonstrated superior weight reduction and cardiometabolic benefits compared with traditional glucagon-like peptide-1 receptor agonists (GLP-1RAs), but its impact on post-ablation outcomes remains uncertain. We compared clinical outcomes among patients treated with tirzepatide versus GLP-1RAs following AF ablation.
Methods
We conducted a retrospective cohort study using the TriNetX Global Research Network. Adult patients with AF who underwent catheter ablation and subsequently received either tirzepatide or a GLP-1RA were identified. After 1:1 propensity score matching, 1,661 patients remained in each cohort. The primary outcome was AF recurrence. Secondary outcomes included progression to permanent AF, repeat AF ablation, all-cause mortality, ischemic stroke, heart failure hospitalization, cardioversion, atrioventricular nodal ablation, and amiodarone use. Risk ratios (RRs) with 95% confidence intervals (CIs) were calculated.
Results
Compared with GLP-1RAs, tirzepatide was associated with a significantly lower risk of AF recurrence (35.8% vs 42.4%; RR 0.85, 95% CI 0.78-0.92; p
Zitieren
APA
Bahar, A. R., Bahar, Y., Hewadmal, H., Raheem, S. Z., & Crawford, T. (2026). Abstract 7745: Dual versus Single Incretin Receptor Agonism After Atrial Fibrillation Ablation: A Propensity-Matched Cohort Study. Circulation, 154(Suppl_1). https://doi.org/10.1161/circ.154.suppl_1.7745
Vancouver
Bahar AR, Bahar Y, Hewadmal H, Raheem SZ, Crawford T. Abstract 7745: Dual versus Single Incretin Receptor Agonism After Atrial Fibrillation Ablation: A Propensity-Matched Cohort Study. Circulation. 2026;154(Suppl_1). doi:10.1161/circ.154.suppl_1.7745
BibTeX
@article{Bahar2026,
author = {Bahar, Abdul Rasheed and Bahar, Yasemin and Hewadmal, Hewad and Raheem, Shaheena Z and Crawford, Thomas},
title = {Abstract 7745: Dual versus Single Incretin Receptor Agonism After Atrial Fibrillation Ablation: A Propensity-Matched Cohort Study},
journal = {Circulation},
year = {2026},
volume = {154},
number = {Suppl_1},
doi = {10.1161/circ.154.suppl_1.7745}
}
EUVIMED